Companies: 10,795·Total market cap: $144.5T
SciSparc Ltd.

SciSparc Ltd.

SPRCNASDAQHealthcare● Active
$10.42
$-1.02(-8.92%)
Market Cap$602682
P/E Ratio
52W High$80.1
52W Low$2.98
Overview

SciSparc Ltd.(SPRC)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · SPRC · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-231.49sprc eps ttm · sprc earnings per shareEarnings history
PE Ratio (TTM)sprc pe ratio ttm · sprc price to earningsPE Ratio deep dive
Revenue (TTM)$2.2Msprc revenue ttm · sprc annual revenueFull revenue history
Dividend Yield不分红does sprc pay dividends · sprc dividend yieldDividend history
Shares Outstanding13.8Msprc shares outstanding · sprc floatShares outstanding history
Next EarningsTBAsprc earnings date · sprc next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$856000.00▼ 34.46% YoY
202320242025
scisparc ltd. revenue · sprc revenue 2025
FY 2025Net Income-$12.2M▼ 93.81% YoY
202320242025
scisparc ltd. net income · sprc profit 2025
FY 2025EPS$-882.64▼ 8980.66% YoY
202320242025
sprc eps · scisparc ltd. earnings per share 2025
TTM:Revenue: $2.2MNet Income: -$18.5MEPS: $-231.49View income statement →

股票表现

完整历史
1D-8.92%
1W-23.10%
1M+66.72%
3M+85.74%
YTD-14.87%
1Y-83.05%
5Y-99.95%

关于 SciSparc Ltd.

CEOOz Adler
IPO DateAug 30, 2021
Employees2
CountryIL

SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key…

what is scisparc ltd. · sprc stock overview · scisparc ltd. company profile · who is scisparc ltd. ceo · sprc NASDAQ · scisparc ltd. headquarters · scisparc ltd. business segments

关于股票概览与关键数据

SciSparc Ltd.(SPRC)是 Biotechnology 行业的 Healthcare 类公司,于 Aug 30, 2021 在 NASDAQ 上市。截至最近交易日,SPRC 股价为 $10.42,市值约为 $602,682。过去12个月累计回报 -83.05%,年初至今回报 -14.87%。

2025 财年 SciSparc Ltd. 营收 $856000.00。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,SciSparc Ltd.(SPRC)股价为 $10.42,在 NASDAQ 上市,52周区间为 $2.98 – $80.10。

SPRC 最新股价SPRC quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议